Skip to main content

Table 1 Demographic and clinical features of patients

From: Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial

  

Placebo

Bupropion

P-value

Age (mean ± standard division)

60.21 ± 9.9

53.69 ± 12.87

0.15

Sex (number)

Male

7

4

0.31

Female

7

9

Diagnosis (number)

Breast cancer

5

5

0.94

Colorectal cancer

4

3

Prostate cancer

2

2

Gastric cancer

2

1

Other cancers

1

2

Other treatments (number)

Radiotherapy

7

4

0.33

Surgery

5

4

Radiotherapy + surgery

2

5